Spotlights of New Clinical Trials; Deep Dive and Key Message
8:40 AM - 9:54 AM
Presentation Theater, Level 1
Moderator(s): Adnan Kastrati, Spencer B. King III
Discussant(s): Takashi Akasaka, Justin E. Davies, Nils Johnson, Neal S. Kleiman, Horst Sievert, Alan C. Yeung
8:40 AM SURTAVI: Step-by-Step Moving Forward to Low Risk and Younger Patients
Lecturer: Eberhard Grube
8:50 AM Discussion
Discussant(s): Horst Sievert, Darren L. Walters
8:54 AM Updated DES Trials: Contemporary and Future Devices
Lecturer: Adnan Kastrati
9:02 AM Discussion
Discussant(s): Spencer B. King III, Alan C. Yeung
9:06 AM [Web-based Lecture] ABSORB-II: BRS Safety Concerns or Still Promising
Lecturer: Stephen G. Ellis
9:14 AM Discussion
Discussant(s): Alan C. Yeung
9:18 AM ILLUMEN-3 and Others: Imaging-Guided PCI Optimization
Lecturer: Akiko Maehara
9:26 AM Discussion
Discussant(s): Takashi Akasaka
9:30 AM EMERALD Study: Exploring the MEchanism of the Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and ComputationaL Fluid Dynamics
Lecturer: Bon-Kwon Koo
9:38 AM Discussion
Discussant(s): Justin E. Davies, Nils Johnson
2017 New Data from AMC; Novel and More
9:54 AM - 11:06 AM
Presentation Theater, Level 1
Moderator(s): Spencer B. King III, Imad Sheiban
Discussant(s): William F. Fearon, Yves R. Louvard, Horst Sievert
9:54 AM IRIS-MAIN Registry: Assessing Generalizability of EXCEL and NOBLE
Lecturer: Pil Hyung Lee
10:02 AM Discussion
, Imad Sheiban
10:06 AM Asan-MV Registry: Confusing MI Definition in Studies Comparing PCI and CABG
Lecturer: Min Soo Cho
10:14 AM Discussion
Discussant(s): David R. Holmes, Adnan Kastrati
10:18 AM How To Manage Grey Zone FFR?: Data from IRIS FFR Registry
Lecturer: Seung-Jung Park
10:26 AM Discussion
Discussant(s): William F. Fearon, Nico Pijls
10:30 AM Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
Lecturer: Jung-Min Ahn
10:38 AM Discussion
Discussant(s): Horst Sievert, E Murat Tuzcu
10:42 AM DECISION-CTO Trial: Treat or Not Treat CTO
Lecturer: Seung-Whan Lee
10:50 AM Discussion
Discussant(s): Spencer B. King III
10:54 AM IRIS-DES Registry: Temporal Trend of Bifurcation Treatment and Outcome
Lecturer: Se Hun Kang
11:02 AM Discussion
, Yves R. Louvard
TCTAP 2017-Late Breaking Clinical Trials from Abstracts
11:06 AM - 12:18 PM
Presentation Theater, Level 1
Moderator(s): David R. Holmes, Chiung-Jen Wu
Discussant(s): Davide Capodanno, Michael Haude, Yves R. Louvard, Teguh Santoso
11:06 AM [TCTAP A-004] Early Clinical Outcomes Following "Off-" Versus "On-label" Indications of Bioresorbable Vascular Scaffolds for the Treatment of 1505 Patients with Coronary Artery Disease: Results from the Prospective ”°Registro Absorb Italiano”± (RAI Registry)
Abstract Presenter: Alfonso Ielasi
11:14 AM Discussion
Discussant(s): David R. Holmes, Chiung-Jen Wu
11:18 AM [TCTAP A-002] Bioresorbable Vascular Scaffold in Real World Practice: Single Center Experiences
Abstract Presenter: Jing-Yi Jhang
11:26 AM Discussion
Discussant(s): Yves R. Louvard
11:30 AM [TCTAP A-006] Early Experience and Favorable Clinical Outcomes of Everolimus-eluting Bioresorbable Scaffolds for Coronary Artery Disease in Korea; Excellent Procedural Outcome with Intravascular Imaging Support
Abstract Presenter: Anthony Yiu Tung Wong
11:38 AM Discussion
Discussant(s): Chiung-Jen Wu
11:42 AM [TCTAP A-001] Thirty-day Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients Presenting with Acute Coronary Syndromes Versus Stable Coronary Artery Disease: Results from the Italian RAI Registry
Abstract Presenter: Elisabetta Moscarella
11:50 AM Discussion
Discussant(s): Davide Capodanno
11:54 AM [TCTAP A-005] A Hybrid Strategy with Bioresorbable Vascular Scaffolds and Drug Eluting Stents for Treating Complex Coronary Lesions
Abstract Presenter: Alfonso Ielasi
12:02 PM Discussion
Discussant(s): Michael Haude
12:06 PM [TCTAP A-003] First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial
Abstract Presenter: Ashok Seth
12:14 PM Discussion
, Teguh Santoso